These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 23540178)

  • 21. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.
    Joint Task Force of the EFNS and the PNS
    J Peripher Nerv Syst; 2005 Sep; 10(3):220-8. PubMed ID: 16221283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous immunoglobulin therapy for neuromuscular disorders.
    Ross MA
    Semin Neurol; 2007 Sep; 27(4):340-6. PubMed ID: 17701871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoglobulin Treatment in Neuromuscular Medicine.
    Burakgazi AZ
    J Clin Neuromuscul Dis; 2019 Jun; 20(4):182-193. PubMed ID: 31135621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consensus statement: the use of intravenous immunoglobulin in the treatment of neuromuscular conditions report of the AANEM ad hoc committee.
    Donofrio PD; Berger A; Brannagan TH; Bromberg MB; Howard JF; Latov N; Quick A; Tandan R
    Muscle Nerve; 2009 Nov; 40(5):890-900. PubMed ID: 19768755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin.
    Soueidan SA; Dalakas MC
    Pediatr Res; 1993 Jan; 33(1 Suppl):S95-100. PubMed ID: 8433882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Updated consensus statement: Intravenous immunoglobulin in the treatment of neuromuscular disorders report of the AANEM ad hoc committee.
    Tavee J; Brannagan TH; Lenihan MW; Muppidi S; Kellermeyer L; D Donofrio P;
    Muscle Nerve; 2023 Oct; 68(4):356-374. PubMed ID: 37432872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Intravenous Immunoglobulin in Neurological Diseases.
    Lünemann JD; Quast I; Dalakas MC
    Neurotherapeutics; 2016 Jan; 13(1):34-46. PubMed ID: 26400261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical applications of intravenous immunoglobulins in neurology.
    Hughes RA; Dalakas MC; Cornblath DR; Latov N; Weksler ME; Relkin N
    Clin Exp Immunol; 2009 Dec; 158 Suppl 1(Suppl 1):34-42. PubMed ID: 19883422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review.
    Fergusson D; Hutton B; Sharma M; Tinmouth A; Wilson K; Cameron DW; Hebert PC
    Transfusion; 2005 Oct; 45(10):1640-57. PubMed ID: 16181216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous immunoglobulin treatment of neurological autoimmune diseases.
    Stangel M; Hartung HP; Marx P; Gold R
    J Neurol Sci; 1998 Jan; 153(2):203-14. PubMed ID: 9511879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IGIV in neurology--evidence and recommendations.
    Bril V; Allenby K; Midroni G; O'Connor PW; Vajsar J
    Can J Neurol Sci; 1999 May; 26(2):139-52. PubMed ID: 10352875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intravenous immunoglobulin (IVIG)].
    Hara M
    Nihon Rinsho; 2009 Mar; 67(3):599-605. PubMed ID: 19280939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous immunoglobulin in MS: promise or failure?
    Fazekas F; Strasser-Fuchs S; Hommes OR
    J Neurol Sci; 2007 Aug; 259(1-2):61-6. PubMed ID: 17449063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous polyclonal human immunoglobulins in multiple sclerosis.
    Soelberg Sorensen P
    Neurodegener Dis; 2008; 5(1):8-15. PubMed ID: 18075269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current use of immunoglobulins in neurology].
    Cursiefen S; Mäurer M
    Nervenarzt; 2008 Sep; 79 Suppl 2():67-74; quiz 75-6. PubMed ID: 18679643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous immunoglobulin therapy for neurological disorders.
    Harkins C; Hammond-Tooke G; Faed J
    N Z Med J; 2009 Oct; 122(1305):41-6. PubMed ID: 19966877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.
    Joint Task Force of the EFNS and the PNS
    J Peripher Nerv Syst; 2006 Mar; 11(1):1-8. PubMed ID: 16519777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.
    Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.
    Nosadini M; Mohammad SS; Suppiej A; Sartori S; Dale RC;
    Dev Med Child Neurol; 2016 Nov; 58(11):1180-1192. PubMed ID: 27242065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.